flolan 1.5 mg powder and solvent for solution for infusion
glaxosmithkline (ireland) limited - epoprostenol - powder and solvent for solution for infusion - 1.5 milligram(s) - platelet aggregation inhibitors excl. heparin; epoprostenol
flolan 0.5 mg powder and solvent for solution for infusion
glaxosmithkline (ireland) limited - epoprostenol - powder and solvent for solution for infusion - 0.5 milligram(s) - platelet aggregation inhibitors excl. heparin; epoprostenol
veletri
janssen-cilag (new zealand) ltd - epoprostenol sodium 1.593mg equivalent to epoprostenol 1.5 mg - powder for injection - 1.5 mg - active: epoprostenol sodium 1.593mg equivalent to epoprostenol 1.5 mg excipient: arginine sodium hydroxide sucrose - veletri is indicated for the long-term treatment, via continuous intravenous infusion, in who functional class iii and iv patients with: · idiopathic pulmonary arterial hypertension · familial pulmonary arterial hypertension · pulmonary arterial hypertension asscociated with the scleroderma spectrum of diseases.
veletri
janssen-cilag (new zealand) ltd - epoprostenol sodium 531ug equivalent to epoprostenol 500 mcg - powder for injection - 500 mcg - active: epoprostenol sodium 531ug equivalent to epoprostenol 500 mcg excipient: arginine sodium hydroxide sucrose - veletri is indicated for the long-term treatment, via continuous intravenous infusion, in who functional class iii and iv patients with: · idiopathic pulmonary arterial hypertension · familial pulmonary arterial hypertension · pulmonary arterial hypertension associated with the scleroderma spectrum of diseases.
veletri 0.5 milligram powder for solution for infusion
janssen-cilag international nv - epoprostenol - powder for solution for infusion - 0.5 milligram(s) - platelet aggregation inhibitors excl. heparin; epoprostenol
flolan 0,5 mg inf. sol. (pwdr. + solv.) i.v. vial
glaxosmithkline pharmaceuticals sa-nv - epoprostenol sodium - eq. epoprostenol 0,5 mg - powder and solvent for solution for infusion - 0,5 mg - epoprostenol sodium - epoprostenol
flolan 1,5 mg inf. sol. (pwdr. + solv.) i.v. vial
glaxosmithkline pharmaceuticals sa-nv - epoprostenol sodium - eq. epoprostenol 1,5 mg - powder and solvent for solution for infusion - 1,5 mg - epoprostenol sodium - epoprostenol
flolan 1,5 mg inf. sol. (pwdr.) i.v. vial
glaxosmithkline pharmaceuticals sa-nv - epoprostenol sodium - eq. epoprostenol 1,5 mg - powder for solution for infusion - 1,5 mg - epoprostenol sodium - epoprostenol
flolan 0,5 mg inf. sol. (pwdr. + solv.) i.v. vial
glaxosmithkline pharmaceuticals sa-nv - epoprostenol sodium - eq. epoprostenol 0,5 mg - powder and solvent for solution for infusion - 0,5 mg - epoprostenol sodium - epoprostenol
flolan 0,5 mg inf. sol. (pwdr.) i.v. vial
glaxosmithkline pharmaceuticals sa-nv - epoprostenol sodium - eq. epoprostenol 0,5 mg - powder for solution for infusion - 0,5 mg - epoprostenol sodium - epoprostenol